Atlas Trials

Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia

Clinical trial NCT00080327 · COMPLETED

Trial details

NCT number
NCT00080327
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2003-11-01
Primary completion
2004-09-01
Enrollment
370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.